Retraction

Biomarkers for Breast Adenocarcinoma Using In Silico Approaches

Citations (6)

6
Total Citations
1
Post-Retraction
(16.7%)
4
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
89 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway
Bin Liu, Xin Zheng, Jiajun Li et al. (7 authors)
BMC Cancer Open Access
Published: Nov 2023
2 citations
89 days after retraction
Clinical plasma cells-related genes to aid therapy in colon cancer
Qi Zhang, Xiao Feng, Mingming Zhang et al. (11 authors)
BMC Genomics Open Access
Published: Aug 2023
1 citation
8 days before retraction
Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment
Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor et al. (4 authors)
Cancers Open Access
Published: Jul 2023
52 citations
37 days before retraction
Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer
Foad Rommasi
Scientific Reports Open Access
Published: May 2023
5 citations
76 days before retraction
Retracted: Biomarkers for Breast Adenocarcinoma Using In Silico Approaches
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine Open Access
Published: Jan 2023
220 days before retraction
Quick Stats
Total Citations: 10
Years Since Retraction: 2.3 years
Open Access: Yes
Last Checked: Jul 24, 2025